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ABSTRACT
Aims To use Mendelian randomization to assess whether alcohol intake was causally associated with cognitive
function. Design Mendelian randomization using a genetic variant related to alcohol intake (ADH1B rs1229984)
was used to obtain unbiased estimates of the association between alcohol intake and cognitive performance.
Setting Europe. Participants More than 34 000 adults.Measurements Any versus no alcohol intake and units of
intake in the previousweekwasmeasured by questionnaire. Cognitive functionwas assessed in terms of immediate and
delayed word recall, verbal fluency and processing speed. Findings Having consumed any versus no alcohol was
associated with higher scores by 0.17 standard deviations (SD) [95% confidence interval (CI) = 0.15, 0.20] for imme-
diate recall, 0.17 SD (95% CI = 0.14, 0.19) for delayed recall, 0.17 SD (95% CI = 0.14, 0.19) for verbal fluency and
0.12 SD (95% CI = 0.09, 0.15) for processing speed. The minor allele of rs1229984 was associated with reduced odds
of consuming any alcohol (odds ratio = 0.87; 95% CI = 0.80, 0.95; P = 0.001; R2 = 0.1%; F-statistic = 47). In Men-
delian randomization analysis, the minor allele was not associated with any cognitive test score, and instrumental
variable analysis suggested no causal association between alcohol consumption and cognition: −0.74 SD (95%
CI = −1.88, 0.41) for immediate recall, −1.09 SD (95%CI = −2.38, 0.21) for delayed recall, −0.63 SD (95%CI = −1.78,
0.53) for verbal fluency and −0.16 SD (95% CI = −1.29, 0.97) for processing speed. Conclusions The Mendelian
randomization analysis did not provide strong evidence of a causal association between alcohol consumption and
cognitive ability.
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INTRODUCTION
Numerous observational cross-sectional and longitudi-
nal studies have examined the relationship of drinking
alcohol with cognition [1–4]. The findings suggest that
light-to-moderate drinking reduces the risk of all forms of
dementia and is associated with higher cognition test
scores. However, observational studies are susceptible to
reverse causality or confounding biases, and therefore
may not be well suited to elucidate the true effects of
alcohol intake. For example, drinkers with alcohol-
related health problems, such as impaired cognition, may
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stop drinking; in this case, non-drinkers would appear to
have lower cognitive scores than current drinkers.
Mendelian randomization takes advantage of the pro-
perties of genetic variants present from birth and allo-
cated at random according to Mendel’s second law [5–8].
Gene variants associated with alcohol intake can be used
to evaluate the potentially unbiased effects of alcohol on
health outcomes [9]. This approach was used recently
by a study of Chinese individuals (n = 4200) in which a
genetic marker in the alcohol-metabolizing gene,ALDH2,
was used as an instrument for alcohol exposure [10]; the
study found no association between moderate alcohol
intake and cognition in instrumental variable analysis.
However, this study was relatively small, and limited
to light and moderate drinking East Asian men. Larger
studies, which include women and a greater range of
alcohol intake, are needed to further investigate the
inconsistency between observation and Mendelian
randomization findings.
In populations of European descent ALDH2 SNP
rs671 is monomorphic, preventing its use in Mende-
lian randomization. However, a non-synonymous SNP
(rs1229984) in the ADH1B gene, encoding one of
the alcohol dehydrogenase family of enzymes (alcohol
dehydrogenase 1B, ADH1B), is suitable for Mende-
lian randomization [11]. Alcohol dehydrogenases are
involved in metabolizing most of ingested alcohol
[12,13]. In-vitro studies have shown that A carriers
of ADH1B rs1229984 have higher ADH1B enzymatic
activity than G/G wild-type [14], and studies in humans
have demonstrated that carriers of the A allele are less
likely to drink alcohol and, if they do, have lower con-
sumption than GG homozygotes [11,15]. Several previ-
ous studies have used ADH1B rs1229984 in Mendelian
randomization studies of various outcomes [16–18].
We investigated the association of rs1229984 with
cognitive performance in six large epidemiological
cohorts comprising more than 34 000 European par-
ticipants, to obtain unbiased estimates of the association
between alcohol consumption and cognitive function.
METHODS
Ethics statement
All studies were approved by ethical committees in each
participating centre and at UCL. All participants provided
written consent to participate in the study.
Study populations and study participants
These analyses combine data from the following large
epidemiological cohorts.
English Longitudinal Study of Ageing (ELSA)
The ELSA sample was drawn from households that
responded to the Health Survey for England (HSE) in
1998, 1999 and 2001. Households were included in
ELSA if one or more resident was aged 50 years or more.
There were 19 924 individuals in households that
responded to HSE who would have been aged 50 by the
time the ELSA sample was taken in 2002. Two thousand,
five hundred and six of these older individuals died or
were ineligible for follow-up; of the remainder, 11 392
(65.7%) became ELSA respondents. More detail has been
reported elsewhere [19,20]. Data used here are from
the second wave of ELSA (2004), in which there were
7079 participants of a clinic visit; of these 5642 white/
European participants provided DNA.
Whitehall II study
The Whitehall II cohort initially recruited 10 308 parti-
cipants between 1985 and 1988 (Phase 1) from 20
London-based civil service departments [21]. These par-
ticipants were re-contacted between 1989 and 2004 on
seven occasions. Data reported here are from Phase
7 (2002–04) of the Whitehall II study. Of 6941 partici-
pating at Phase 7, 6483 (93.4%) had a clinical assess-
ment during which cognitive function assessments
were administered. Of these, DNA is available from 5059
white/European participants.
Health, Alcohol and Psychosocial Factors In Eastern Europe
(HAPIEE) study
The HAPIEE study recruited four random urban popula-
tion samples of men and women aged 45–69 years at
baseline in 2002–05 in Novosibirsk (Russia), Kaunas
(Lithuania), Krakow (Poland) and six towns in the Czech
Republic [22]. Cognitive function was assessed in a
subsample of participants at baseline and for the total
sample at re-examination in 2006–08; during the
re-examination, a fourth cohort in Kaunas (Lithuania)
was established. A total of 36 030 people were recruited
(overall response rate 61%), of whom 23 884 partici-
pants had data on bothADH1B rs1229984 genotype and
cognition. Where participants had repeated measure-
ments of cognitive function, the first measurement was
used in the analysis.
Measurements
In each study, participants completed questionnaires,
underwent a clinical examination and provided blood
samples.
Alcohol intake
Of the various aspects of alcohol consumption collected
in each cohort, the measure comparable across cohorts
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was weekly consumption of alcohol. In ELSA andWhite-
hall II, the question related to intake during the last week
(reported in British units) and in the HAPIEE cohorts,
to a typical week (reported in litres and millilitres). For
the purposes of this analysis, we converted all values to
British units (1 British unit = 8 g of ethanol). Given the
relatively small proportion of participants who reported
consuming more than the recommended amounts
(28 units perweek inmen and 21units inwomen), drink-
ers in our cohorts largely represent light-to-moderate
drinkers.
Cognitive performance
Memory was assessed by immediate recall (all cohorts)
and delayed recall (ELSA and HAPIEE cohorts). In ELSA,
10 common words were read out by a computer at
a rate of one word every 2 seconds. The sound level was
adjusted to meet the requirements of each participant.
Participants were asked to recall as many words as possi-
ble immediately and again after a short delay, during
which they completed other cognitive tests. Four different
randomly assigned word lists were used, and members of
the same household were given different versions. White-
hall II participants were given 1minute to write down the
number of words remembered. In the HAPIEE cohorts, a
list of the same 10 words was read by an interviewer
(baseline) or from a computer (re-examination) three
times. Participants were asked to recall verbally as many
words as possible immediately and then again after com-
pleting all other cognitive tests. The sum of the three
immediate recalls was used in the analysis.
Verbal (semantic) fluency was assessed in all cohorts
by recalling as many animals as possible in 1 minute. In
HAPIEE and ELSA cohorts recall was verbal and results
were recorded by the interviewer, while in Whitehall II,
participants were asked to write down their responses.
Processing speed was assessed in ELSA and HAPIEE
using the letter cancellation test. Participants were asked
to cross out as many of the 65 target letters (‘P’ and ‘W’,
‘P’ and ‘III’ in Russia) as possible in 1 minute on a page
incorporating 780 letters in a grid. The total number of
correctly letters crossed-out letters was used as ameasure
of processing speed.
Genotyping and quality control
The rs1229984 variant in ADH1B was genotyped in
all six cohorts. Genotyping was carried out using
the Kaspar genotyping platform by KBioscience
(www.lgcgenomics.com) in Russian, Polish and Lithu-
anian HAPIEE samples and in ELSA and Whitehall
II studies. Czech HAPIEE samples were genotyped at
the Institute of Clinical and Experimental Medicine,
Prague. A subsample of 100 samples was genotyped
at both laboratories, with 99% agreement. In all
cohorts, the call rate was >98% and the rs1229984
SNP was in Hardy–Weinberg equilibrium at P > 0.001
(Table 1).
Confounders and mediators
Sex and age were obtained from questionnaire informa-
tion in each of the cohorts. Age was used in analysis in
Table 1 Descriptive characteristics of the analytical samples.
HAPIEE Czech
Republic
HAPIEE
Russia
HAPIEE
Poland
HAPIEE
Lithuania
Whitehall
II ELSA
No. subjects 5607 5814 5627 6836 5031 5537
Age, mean, SD, years 59.1 (7.0) 59.7 (6.9) 58.8 (7.0) 60.9 (7.6) 55.3 (6.0) 66.1 (9.8)
% women 55 57 51 54 26 54
Cognitive function (mean, SD)
Word recall (max. 30)a 22.6 (3.6) 20.9 (4.6) 20.4 (4.3) 21.8 (4.1) 7.1 (2.4) 5.7 (1.9)
Delayed recall (max. 10) 7.6 (1.8) 7.0 (2.2) 7.1 (1.9) 7.7 (1.9) NA 4.4 (2.1)
Verbal fluency 23.6 (6.6) 18.6 (7.1) 21.0 (6.3) 21.4 (6.2) 16.95 (4.0) 20.2 (6.5)
Letter search 17.9 (4.7) 17.0 (5.4) 18.0 (5.8) 16.2 (4.8) NA 10.4 (3.6)
Weekly alcohol intake, n (median, IQR) 5491 (5, 18) 5813 (0, 3) 5556 (0, 6) 6812 (2, 6) 4644 (10, 17) 4587 (2, 12)
ADH1B genotype, n (%)
GG 5024 (89.6) 5203 (89.5) 5055 (89.8) 6375 (93.3) 4758 (94.6) 5235 (94.6)
AG 568 (10.1) 601 (10.3) 552 (9.8) 457 (6.7) 266 (5.3) 291 (5.3)
AA 15 (0.3) 10 (0.2) 20 (0.4) 4 (0.1) 7 (0.1) 11 (0.02)
HWE P-value P = 0.90 P = 0.09 P = 0.23 P = 0.20 P = 0.11 P = 0.004
Call rate (%) 99.6 98.7 98.8 98.9 99.3 98.8
aWord recall was based on 30 words in the Health, Alcohol and Psychosocial factors In Eastern Europe (HAPIEE) study and 10 words in the
Whitehall II study. ELSA = English Longitudinal Study of Ageing; HWE = Hardy–Weinberg equilibrium; IQR = interquartile range; NA = not available;
SD = standard deviation; AD1HB = alcohol dehydrogenase 1B.
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5-year age-bands. Educational attainment, which is con-
sidered as a mediator in the association of alcohol intake
and cognitive performance, is categorized as attain-
ment of primary, vocational, secondary and university/
postgraduate education.
Statistical analyses
All cognitive test results were standardized (mean = 0,
standard deviation = 1) to allow comparison between
tests. A dominant model was used for genetic analyses;
that is, AA carriers and GA carriers were compared to
the GG reference group. Owing to a skewed distri-
bution, alcohol intake in units per week was natural
log-transformed. A value of 1 was added prior to log-
transformation in order to preserve values for individuals
who consumed no alcohol.
We generated a pooled data set for the analyses and
adjusted for study cohort. First, we examined the obser-
vational association between alcohol and cognitive traits.
To do this, we generated categories of alcohol consump-
tion (0, >0–<5, ≥5–<10, ≥10–<15, ≥15–<20, ≥20 British
units/week) and conducted linear regression analyses
with the cognition traits as dependent variables and
alcohol categories as the independent variable, adjusted
for age group (used in 5-year age-bands) and sex. Indi-
viduals reporting 0 units/week alcohol were used as the
reference group.
Secondly, we investigated the association of the gene
variant on any versus no alcohol and on alcohol in-
take in log weekly units per week. Because a Mendelian
randomization analysis is conducted in part to remove
potential confounders, we also investigated the associa-
tion between the rs1229984 A-allele and common con-
founding factors, such as age, sex and smoking.
Educational attainment was considered a potential
mediator in the association of rs1229984 A-allele with
cognition.
We investigated the association of the rs1229984
A-allele with cognitive traits overall and separately for
those who reported no drinking versus those who report
alcohol intake. We conducted a test for interaction
between ADH1B rs1229984 and each cognitive trait
stratified by any versus no alcohol consumption under
the hypothesis that the ADH1B rs1229984 variant
would only act in individuals exposed to alcohol; a small
P-value for interaction would provide evidence of a dif-
ferential effect of the genetic variant according to alcohol
consumption.
Thirdly, we used the gene variant to estimate the
unconfounded associations between alcohol and cogni-
tive scores. We used the observational association to
inform on the approach for the instrumental variable
analysis. The observational associations suggested a
plateau effect, where any alcohol consumption per week
was associated with higher cognitive scores compared
with individuals consuming 0 units per week, with no
apparent gradient among drinkers. We dichotomized
the alcohol exposure into any versus none per week,
and used the gene variant to instrument this alcohol phe-
notype. The instrumental variable estimates therefore
relate to the effect of any alcohol comparedwith none per
week on cognitive function. In sensitivity analysis, we
used the genetic variant to instrument volume of alcohol
in log-weekly units. We used two-stage least-squares
instrumental variable analysis using the ‘ivregress’
command in Stata version 12.0 (StataCorp, College
Station, TX, USA). The analyses were repeated after
excluding individuals consuming more than the recom-
mended limit to examine light-to-moderate drinking.
Finally, to maximize use of the available data, we com-
bined our findings with those from a recently published
study using the ALDH2 gene [10]. We generated instru-
mental variables estimates for a 1-unit increase in alcohol
per day and its effect on delayed recall in our pooled data
set. Using this instrumental variable estimate, we con-
ducted a fixed-effects meta-analysis using the previously
published instrumental variable estimate for a compara-
ble difference in alcohol on a delayed 10-word recall trait.
RESULTS
General characteristics
There were 34 452 individuals in the analysis, with a
mean age ranging from 44 to 66 years; 50% of partici-
pants were female. The median alcohol consumption in
the pooled data set was 2.3 units per week [interquartile
range (IQR) 0, 11.4]. No major differences in cogni-
tive test scores among the six cohorts were observed;
the lower scores in ELSA reflected the older age of partici-
pants in this cohort (Table 1).
Observational associations between alcohol and
cognition traits
Scores for all four cognitive traits were higher in individu-
als who consumed any alcohol compared to individuals
who consumed no alcohol per week, with a ‘plateau’
effect whereby the greatest difference in cognitive func-
tion was between individuals who reported drinking 0
units per week and individuals who consumed between
>0 to <5 units per week, and no difference within indi-
viduals who consumed any alcohol per week (Fig. 1).
Association of ADH1B rs1229984 with alcohol intake
Carriage of the A-allele of rs1229984 was associ-
ated with a 10.3% lower alcohol intake per week
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[95% confidence interval (CI) = 5.6%, 14.7%) with an
F-statistic of 41 and R2 of 0.1%. The corresponding
odds ratio for any versus no weekly alcohol was 0.87
(95%CI = 0.80, 0.95) (Table 2) with F-statistic of 47 and
R2 = 0.1%.
Association of ADH1B rs1229984 with age, sex,
smoking and educational attainment
No association was found between carriage of the
A-allele of rs1229984 with age. However, a weak
Figure 1 Observational association between alcohol intake (categories of volume compared to no alcohol) and cognitive traits. Estimates
are adjusted for age group and sex. Blue dots represent the mean and red whiskers represent the 95% confidence interval
Table 2 Difference in alcohol phenotypes, age, sex, smoking status and educational attainment between the ADH1B rs1229984
A-allele carriers versus GG homozygotes (reference group).
Trait No. with a trait/total Effect estimate (95% CI) P-value
Alcohol traits
Units/week NA/32 903 −10.3% (−14.7%, −5.6%)a 3.1 × 10−5
Any versus no alcohol intake per week 18 778/32 903 0.87 (0.80, 0.95)b 0.001
Confounders
Age group, years (<50, ≥50–<55, ≥55–<60,
≥60–<65, ≥65–<70, ≥70–<75, ≥75–<80.
≥80–<85, ≥85–<90, ≥90)
NA/34 316 1.01 (0.95 1.09)c 0.71
Sex (male) 17 116/34 431 1.10 (1.01, 1.19)b 0.024
Smoking status (ever versus none) 16 671/33 897 1.080 (0.998, 1.170)b 0.06
Potential mediator
Educational attainment (primary, vocational,
secondary, university)
NA/33 726 1.14 (1.06, 1.22)c 3.0 × 10−4
aLinear regression coefficient; bodds ratio; cestimates obtained from ordered logistic regression, therefore the odds ratio refers to the odds of increasing
from one category to the next higher. CI = confidence interval; NA = not available.
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association was identified with male sex [odds ratio (OR)
= 1.10; 95% CI = 1.01, 1.19; P = 0.02) and smoking
status (OR = 1.08; 95% CI = 1.00–1.17; P = 0.06) while
the association with educational attainment was signifi-
cant (OR = 1.14; 95% CI = 1.06, 1.22 for each unit
increase in educational category; P = 3 × 10−4, Table 2).
Association of ADH1B rs1229984 with cognitive traits
overall and stratified by alcohol consumption
We found no association between carriage of the A-allele
of rs1229984 and cognitive performance, neither overall
nor when stratified by drinking status (into drinking any
versus no alcohol per week) (all P-values >0.1; Table 3).
Using the genotype as a continuous variable produced
similar results. The interaction between alcohol intake
and the rs1229984A-allele carrier statuswas not signifi-
cant (all P-values >0.1), meaning that there was no dif-
ferential association between the rs1229984 A-allele
and cognition when stratified by alcohol consumption.
Contrasting observational to instrumental
variable analyses
Because the observational association between alcohol
intake and cognition suggested that the greatest differ-
ence in cognitive traits was when comparing any alcohol
intake to none per week, we used the rs1229984 variant
to instrument this phenotype. The observational associa-
tions suggest that alcohol intake was associated consist-
ently with higher cognitive scores (Table 4). In contrast,
the instrumental variable estimates for any versus no
alcohol intake per week showed no association between
alcohol intake and cognitive traits. Further, the point esti-
mates from these analyses were directionally opposite to
those of the observational estimates, although the 95%
CI of the instrumental variable estimates were wide and
overlapped those of the observational estimates. Similar
results were apparent when analyses were repeated using
the effect of a 1-log unit increase in alcohol intake per
week (Table 4). We additionally adjusted for educational
attainment and smoking status, and found the instru-
mental variable estimates to remain unaltered (Table 4).
With the exception of delayed recall, P-values for the
Durbin–Wu–Hausman test were >0.05, suggesting no
difference between the observational and instrumental
variable estimates. Repeating the instrumental variable
analyses with participants consuming fewer than recom-
mended drinking limits did not change the results (not
shown).
To maximize use of the available data, we combined
our data with previously published [10] causal estimates
for a 1 unit/day increase in alcohol on delayed recall
using fixed-effects meta-analysis. The combined analysis,
including 32 932 participants, found that a 1-unit/day
increase in alcohol did not associate with delayed recall
(instrumental variable beta coefficient for a 1-unit
increase in alcohol/day: −0.06; 95% CI = −0.20, 0.07),
with low heterogeneity between estimates (I2 = 0%)
(Fig. 2).
DISCUSSION
In data from six large population-based cohorts, we
found strong evidence of alcohol intake associated
with better cognitive performance. However, a Mendelian
randomization analysis, using a genetic variant (ADH1B
Table 3 Association of the alcohol dehydrogenase 1B (ADH1B) rs1229984 A-allele carriagea (versus GG reference group) with
cognitive performance, stratified by alcohol intake.
Cognitive test Alcohol stratum Number
Regression coefficient
(95% CI) P-value
P-value
(interaction)b
Immediate recall All individuals 33 512 0.02 (−0.02,0.06) 0.40 NA
No alcohol 14 016 0.03 (−0.03,0.09) 0.31 0.35
Any alcohol 18 233 0.01 (−0.05,0.07) 0.72
Delayed recall All individuals 29 386 0.03 (−0.02,0.07) 0.20 NA
No alcohol 13 539 0.03 (−0.03,0.09) 0.30 0.53
Any alcohol 14 686 0.03 (−0.03,0.09) 0.36
Verbal fluency All individuals 33 531 0.01 (−0.03,0.05) 0.47 NA
No alcohol 14 032 0.02 (−0.04,0.07) 0.54 0.95
Any alcohol 18 236 0.03 (−0.02,0.09) 0.23
Processing speed All individuals 29 105 −0.01 (−0.05,0.03) 0.68 NA
No alcohol 13 352 −0.02 (−0.08,0.04) 0.56 0.60
Any alcohol 14 592 0.01 (−0.05,0.07) 0.68
aA-allele carriage is associated with reduced alcohol consumption. bLikelihood ratio test for interaction between alcohol intake (any versus none per
week) and ADH1B rs1229984 (A carriage versus GG, reference group) on cognitive performance. Alcohol intake (no alcohol, any alcohol) refers to
consumption per week. The ‘All individuals’ stratum includes participants without measures of alcohol intake. CI = confidence interval; NA = not
available.
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rs1229984) associated strongly with alcohol intake, did
not replicate the observational estimate, although the
confidence intervals were wide due to the genetic instru-
ment explaining only a small proportion of variance of
alcohol intake. Given that the instrumental variable
analysis findings are less likely to be biased than the
observational estimates, our findings do not support the
hypothesis that alcohol consumption has a beneficial
effect on cognitive function.
The main advantage of Mendelian randomization
analysis is that it minimizes bias and confounding that
can hamper observational studies. Although we found a
weak association between the ADH1B rs1229984
variant with sex, this association is most probably a false
positive; in addition, we did not identify differential
effects of the genetic variant on cognitive traits in sex-
stratified analyses (data not shown) and we adjusted for
sex in the instrumental variable analysis. The associa-
tion of the rs1229984 variant with educational attain-
ment may reflect an inverse association of alcohol
consumption in young adulthood with educational
attainment, but could also reflect parental alcohol
intake [23]. We speculate that educational attainment
in early life could be on a causal pathway between
alcohol intake and cognition, given the extensive evi-
dence that education is related causally to cognitive per-
formance [24,25]. However, despite the association of
the genetic variant with educational attainment and a
strong association of education with cognition in our
data, the genetic variant did not associate with cogni-
tion in our analyses.
Our study has several benefits. This is the largest study
conducted thus far to investigate the role of alcohol
on cognition through Mendelian randomization. The
Table 4 Observational and instrumental variable estimates for the association between cognitive phenotype and alcohol intake: any
versus no alcohol per week (upper part) and for a 1-log unit increase in alcohol consumption per week (lower part).
Immediate recall Delayed recall Verbal fluency Processing speed
Any drinking versus none
Observational (1) 0.17 (0.15, 0.20) 0.17 (0.14, 0.19) 0.17 (0.14, 0.19) 0.12 (0.09, 0.15)
Instrumental variable (1) −0.74 (−1.88, 0.41) −1.09 (−2.38, 0.21) −0.63 (−1.78, 0.53) −0.16 (−1.29, 0.97)
P-value (Durbin–Wu–Hausman test) 0.09 0.03 0.15 0.63
Instrumental variable (2) −0.23 (−1.17, 0.72) −0.60 (−1.62, 0.42) −0.16 (−1.13. 0.81) 0.21 (−0.77, 1.19)
P-value (Durbin–Wu–Hausman test) 0.48 0.15 0.61 0.78
For 1-log unit increase in alcohol consumption per week
Observational (1) 0.05 (0.04, 0.06) 0.05 (0.04, 0.06) 0.05 (0.04, 0.06) 0.04 (0.03, 0.05)
Instrumental variable (1) −0.20 (−0.50, 0.10) −0.33 (−0.71, 0.05) −0.17 (−0.48, 0.14) −0.05 (−0.40, 0.30)
P-value (Durbin–Wu–Hausman test) 0.09 0.03 0.14 0.63
Instrumental variable (2) −0.06 (−0.32, 0.20) −0.19 (−0.51, 0.13) −0.04 (−0.31, 0.22) 0.07 (−0.24, 0.38)
P-value (Durbin–Wu–Hausman test) 0.48 0.16 0.60 0.77
Estimates are regression coefficients (95% confidence interval) for drinking any alcohol versus no alcohol per week (upper part) and for a 1-log unit
increase in alcohol volume per week (lower part). (1) Adjusted for age group and sex; (2) adjusted for age, sex, smoking and education. P-value
(Durbin–Wu–Hausman test) represents a test for endogeneity; a small P-value can be interpreted that the observational and instrumental variable
estimate are non-concordant.
Figure 2 Meta-analysis of instrumental
variable estimates to investigate the totality
of available evidence on the association of
alcohol with delayed recall. Instrumental
variable (IV) estimates are for a 1-unit
increase in alcohol per day. Although the
Guangzhou Biobank Cohort Study had
fewer participants, the gene used had a
stronger effect on alcohol consumption
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participating cohorts covered a wide range of societal
contexts with a large variation of drinking patterns and
pronounced differences in health. Although this intro-
duces heterogeneity between the studies, it also allows us
to generalize the association of alcohol intake and cogni-
tive performance, whichwas examined previously only in
a low-consumption East Asian population using theMen-
delian randomization approach [10].Wewere also able to
conduct analyses in a pooled data set inwhich the alcohol
and cognitive traits were harmonized between studies.
Several limitations should be considered when inter-
preting these results. First, while our study contains
data from more than 34 000 participants, very large
numbers of observations are required for an instrumen-
tal variable analysis using a single nucleotide polymor-
phism (SNP) that explains only 0.1% of the R2 of
alcohol. Our Mendelian randomization estimates are
therefore less precise than those of the observational
estimates, and the statistical power to show inverse asso-
ciation with cognitive functions was approximately
10%. Our results should therefore be replicated with
even larger sample sizes (or through using multiple
SNPs in combination to increase the variance explained
in alcohol consumption). While our study was almost
10-fold larger than the one previous Mendelian
randomization study to have addressed this question [9],
our genetic instrument was weaker and our estimates
were therefore less precise. When we incorporated the
published findings with ours similar findings were
obtained, showing a consistent null effect of alcohol on
delayed recall. Further, a recent study in 3542 men
failed to observe an association of association of ADH1B
with cognitive impairment or decline in older age groups
[26]. Despite this, we still cannot exclude the possibility
of a false-negative finding.
Secondly, we used cross-sectional data, rather than
decline in cognitive performance over time. This would be
a severe limitation of a traditional observational study, as
people change their drinking habits over time and drink-
ers often stop drinking because of health or other prob-
lems. However, the Mendelian randomization design
reduces this problem by using a genetic marker of long-
term exposure to alcohol intake.
Thirdly, the four measures of cognition used in these
analyses were limited to those available in the six cohorts
and did not allow investigation of clinically meaningful
cognitive outcomes such as dementia. Nevertheless, cog-
nitive test performance predicts future cognitive impair-
ment and dementia [27], which are proposed to be the
result of long-term processes that occur over decades
[28,29]. As genetic variants are determined at meiosis
and are related to life-long differences between individu-
als, Mendelian randomization is particularly pertinent to
questions concerning effects on conditions with a long
pre-clinical phase, such as cognitive impairment and car-
diovascular disease [18], to minimize bias from reverse
causality.
Fourthly, a possible limitation of Mendelian rando-
mization studies is a potential association of an indirect
variant (ADH1B in our study) with non-endogenous
exposures. However, ADH1B encodes the enzyme alcohol
dehydrogenase 1B, involved in the primary metabolic
pathway of alcohol [30]. It is therefore very unlikely that
ADH1B would directly influence cognition other than
through alcohol.
Fifthly, we used a linear instrumental variable analy-
sis approach, which might seem at odds with the obser-
vational estimates we identified as a non-monotonic
increase in cognitive function with alcohol. For this
reason, we dichotomized alcohol into any versus none
per week, allowing us to mimic the observational rela-
tionship for the instrumental variable analysis. Further-
more, as previous observational studies link better
cognitive function with light-to-moderate drinking, we
conducted additional analyses excluding participants
who drink more than the recommended levels, but the
results remained unaltered.
Finally, population stratification can compromise
Mendelian randomization analysis [31]; however, as our
analyses were restricted to white Europeans with similar
allele frequencies, this is unlikely to be a problem. Fur-
thermore, adjustment for principal components in the
two cohorts in which this was feasible did not alter the
estimate (data available on request).
We conclude that using a Mendelian randomization
approach in a large data set of more than 34 000 indi-
viduals in the general population did not identify strong
evidence of a causal relationship between alcohol intake
and cognitive function, due to limited power. Although
this suggests that the observational estimates may be
influenced by bias or confounding, almost 1 million par-
ticipants would be required for a conclusive Mendelian
randomization study using ADH1B. Therefore, further
Mendelian randomization studies in larger samples
and/or using stronger genetic instruments are required
to replicate these findings.
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